Mar 09, 2020
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
Feb 18, 2020
Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea
Feb 06, 2020
Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology
Jan 14, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.
Jan 09, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne
Nov 04, 2019
Foamix Announces Publication of AMZEEQ(TM) (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology
Oct 18, 2019
Foamix Receives FDA Approval of AMZEEQ(TM) Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
Oct 17, 2019
Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Oct 10, 2019
Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
Aug 05, 2019
Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Aug 03, 2017
Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
Jun 29, 2017
Foamix Pharmaceuticals Appoints David Domzalski as Chief Executive Officer
Jun 15, 2017
Foamix Pharmaceuticals to Present at the 2017 BIO International Convention
Jun 12, 2017
Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%
Jun 01, 2017
Foamix Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference